title: Does electroconvulsive therapy afford protection against olanzapine-induced parkinsonism? A case report.
authors.forename: Seyed Ali
authors.initials: SA
authors.lastname: Dastgheib
authors.forename: Arash
authors.initials: A
authors.lastname: Mowla
authors.forename: Ahmad
authors.initials: A
authors.lastname: Ghanizadeh
authors.forename: Abdul Mohammad
authors.initials: AM
authors.lastname: Khajeian
mesh_terms: D000374:Aggression / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000523:psychology; D008607:Intellectual Disability / Q000150:complications; D000077152:Olanzapine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000517:prevention & control*; D011595:Psychomotor Agitation / Q000523:psychology; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine